Skip to content

    Nutex Health (NUTX) stock price & financials

    View NUTX earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance+110.8% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $78.80M
    $257.62M
    $211.79M
    $243.99M
    $267.80M
    +239.9%
    $151.68M
    -41.1%
    $216.49M
    +2.2%
    $210.75M
    -13.6%
    Weakening
    Operating Profit
    $9.66M
    $114.21M
    $80.66M
    $33.68M
    $130.37M
    +1249.1%
    $30.92M
    -72.9%
    $81.27M
    +0.7%
    $121.72M
    +261.4%
    Strengthening
    Net Profit
    -$8.79M
    $61.70M
    $21.22M
    -$17.70M
    $55.44M
    $11.83M
    -80.8%
    $46.81M
    +120.6%
    $65.84M
    Strengthening
    EPS
    $-1.72
    $11.83
    $3.74
    $-2.95
    $8.27
    $6.70
    +79.1%
    $9.58
    Strengthening
    Other Income
    Interest
    $5.38M
    $5.05M
    $6.12M
    $5.68M
    $5.45M
    +1.3%
    $4.98M
    -1.5%
    $4.68M
    -23.5%
    $4.67M
    -17.7%
    Weakening
    Depreciation
    Profit before Tax
    -$2.58M
    $108.58M
    $71.22M
    $23.73M
    $123.94M
    $25.89M
    -76.2%
    $76.56M
    +7.5%
    $117.08M
    +393.4%
    Strengthening
    MarginsOPM
    12.3%
    44.3%
    38.1%
    13.8%
    48.7%
    +297.1%
    20.4%
    -54.0%
    37.5%
    -1.4%
    57.8%
    +318.5%
    Strengthening
    Tax
    -177.7%
    7.9%
    28.7%
    32.0%
    21.9%
    35.9%
    +352.2%
    18.0%
    -37.1%
    17.7%
    -44.5%
    Strengthening
    ReturnsROIC
    5.1%
    -35.6%
    -12.2%
    10.2%
    -31.9%
    -730.8%
    -6.8%
    +80.8%
    -27.0%
    -120.6%
    -37.9%
    -472.1%
    Weakening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$119.3K$1.07M$26.9K$36.12M$34.26M$22.00M$40.64M$185.57M$205.21M
    Short-Term Investments
    Total Current Assets$305.4K$1.24M$157.1K$154.02M$97.97M$90.85M$292.48M$538.81M$585.65M
    Net PP&E$7.6K$330.5K$12.4K$173.74M$102.56M$93.24M$105.81M$121.54M$121.85M
    Goodwill$0$3.47M$0$1.14M$17.01M$17.07M$13.92M$13.92M$13.92M
    Intangibles$2.57M$1.54M$682.6K$21.19M$20.51M$15.53M$21.23M$20.58M
    Total Assets$449.4K$6.69M$169.9K$394.65M$431.75M$398.25M$655.32M$918.52M$964.63M
    LiabilitiesTotal Current Liabilities$1.04M$4.61M$1.15M$37.69M$54.86M$58.31M$154.22M$157.91M$117.22M
    Short-Term Debt$89.35M$12.55M$10.81M$14.39M$13.34M$8.50M
    Long-Term Debt$300.0K$0$0$78.82M$23.05M$26.31M$22.47M$29.17M$31.11M
    Long-Term Leases$0$223.6K$0$20.82M$19.44M$15.48M$30.62M$30.04M$29.22M
    Total Liabilities$1.95M$4.83M$1.30M$203.07M$311.42M$319.14M$466.79M$495.09M$457.32M
    EquityCommon Stock & APIC$4.6K$5.3K$4.0K$4.3K$4.5K$6.0K$7.0K$7.0K
    Retained Earnings-$5.45M-$12.57M-$18.22M$102.32M-$363.29M-$409.07M-$356.98M-$286.19M-$173.54M
    Total Equity-$1.50M$1.86M-$1.13M$114.65M$95.86M$61.45M$132.44M$329.45M$394.32M
    HighlightsNet Cash / (Debt)-$132.06M-$1.34M-$15.12M$3.78M$143.06M$165.61M

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating-$480.0K-$4.04M$86.67M$173.43M$50.61M$1.26M$23.15M$248.13M$279.62M
    Cash from Investing-$117.0K-$748.2K-$61.19M-$36.98M-$4.34M-$11.24M-$5.61M-$5.24M-$9.12M
    Cash from Financing$704.6K$5.73M-$7.97M-$125.85M-$48.13M-$2.27M$1.09M-$97.95M-$160.43M
    SummaryCapital Expenditure$0-$84.0K-$61.19M-$36.93M-$14.63M-$9.50M-$2.30M-$2.53M-$5.45M
    Free Cash Flow-$480.0K-$4.12M$25.48M$136.51M$35.97M-$8.24M$20.85M$245.60M$274.17M
    FCF Margin-35.1%-301.9%9.3%41.2%16.4%-3.3%4.3%28.1%32.4%

    Ratios